One in twelve physicians, and nearly one in five family medicine physicians, accepted payments from pharmaceutical companies related to opioids, according to a study from Boston Medical Center's Graysen Center for Addiction Medicine and published in the American Journal of Public Health. This is the first large-scale, national study of industry payments involving opioids and suggests that pharmaceutical companies may have a stronger hold than previously known on how doctors prescribe the powerful drugs.
Poll Question:
Do you think physicians who receive drug-firm payments related to opioids run the risk of overprescribing these medications?
Yes
250
No
35
Not Sure
24
